Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.
Compare To Other CompaniesAnnual (shares)
| Value | Reported On | Form | FY | FP | Start Date | End Date | Fiscal Period |
|---|---|---|---|---|---|---|---|
| 1,000,000 | 2014-02-19 | 10-K | 2013 | FY | 2013-01-01 | 2013-12-31 | CY2013 |
Quarterly (shares)
| Value | Reported On | Form | FY | FP | Start Date | End Date | Fiscal Period |
|---|---|---|---|---|---|---|---|
| 700,000 | 2021-05-05 | 10-Q | 2021 | Q1 | 2020-01-01 | 2020-04-02 | CY2020Q1 |
| 700,000 | 2021-08-04 | 10-Q | 2021 | Q2 | 2020-04-03 | 2020-07-02 | CY2020Q2 |
| 900,000 | 2021-11-03 | 10-Q | 2021 | Q3 | 2020-07-03 | 2020-10-01 | CY2020Q3 |
| 1,300,000 | 2022-05-04 | 10-Q | 2022 | Q1 | 2021-01-01 | 2021-04-01 | CY2021Q1 |
| 1,000,000 | 2022-08-03 | 10-Q | 2022 | Q2 | 2021-04-02 | 2021-07-01 | CY2021Q2 |
| 400,000 | 2022-11-03 | 10-Q | 2022 | Q3 | 2021-07-02 | 2021-09-30 | CY2021Q3 |
| 1,100,000 | 2023-05-03 | 10-Q | 2023 | Q1 | 2022-01-01 | 2022-03-31 | CY2022Q1 |
| 0.5 | 2023-08-02 | 10-Q | 2023 | Q2 | 2022-04-01 | 2022-06-30 | CY2022Q2 |
| 0.5 | 2023-11-01 | 10-Q | 2023 | Q3 | 2022-07-01 | 2022-09-29 | CY2022Q3 |
| 0.9 | 2024-05-07 | 10-Q | 2024 | Q1 | 2023-01-01 | 2023-03-30 | CY2023Q1 |
| 400,000 | 2024-08-05 | 10-Q | 2024 | Q2 | 2023-03-31 | 2023-06-29 | CY2023Q2 |
| 600,000 | 2024-11-05 | 10-Q | 2024 | Q3 | 2023-06-30 | 2023-09-28 | CY2023Q3 |
| 9.6 | 2025-05-01 | 10-Q | 2025 | Q1 | 2024-01-01 | 2024-03-28 | CY2024Q1 |
| 8,800,000 | 2024-08-05 | 10-Q | 2024 | Q2 | 2024-03-29 | 2024-06-27 | CY2024Q2 |
| 8,700,000 | 2024-11-05 | 10-Q | 2024 | Q3 | 2024-06-28 | 2024-09-26 | CY2024Q3 |
| 8,600,000 | 2025-05-01 | 10-Q | 2025 | Q1 | 2025-01-01 | 2025-04-03 | CY2025Q1 |
All Reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (shares)
| Value | Reported On | Form | FY | FP | Start Date | End Date | Fiscal Period |
|---|---|---|---|---|---|---|---|
| 1,000,000 | 2014-02-19 | 10-K | 2013 | FY | 2013-01-01 | 2013-12-31 | CY2013 |
| 700,000 | 2021-05-05 | 10-Q | 2021 | Q1 | 2020-01-01 | 2020-04-02 | CY2020Q1 |
| 800,000 | 2021-08-04 | 10-Q | 2021 | Q2 | 2020-01-01 | 2020-07-02 | |
| 700,000 | 2021-08-04 | 10-Q | 2021 | Q2 | 2020-04-03 | 2020-07-02 | CY2020Q2 |
| 700,000 | 2021-11-03 | 10-Q | 2021 | Q3 | 2020-01-01 | 2020-10-01 | |
| 900,000 | 2021-11-03 | 10-Q | 2021 | Q3 | 2020-07-03 | 2020-10-01 | CY2020Q3 |
| 1,300,000 | 2021-05-05 | 10-Q | 2021 | Q1 | 2021-01-01 | 2021-04-01 | |
| 1,300,000 | 2022-05-04 | 10-Q | 2022 | Q1 | 2021-01-01 | 2021-04-01 | CY2021Q1 |
| 1,200,000 | 2021-08-04 | 10-Q | 2021 | Q2 | 2021-01-01 | 2021-07-01 | |
| 1,200,000 | 2022-08-03 | 10-Q | 2022 | Q2 | 2021-01-01 | 2021-07-01 | |
| 1,000,000 | 2021-08-04 | 10-Q | 2021 | Q2 | 2021-04-02 | 2021-07-01 | |
| 1,000,000 | 2022-08-03 | 10-Q | 2022 | Q2 | 2021-04-02 | 2021-07-01 | CY2021Q2 |
| 500,000 | 2021-11-03 | 10-Q | 2021 | Q3 | 2021-01-01 | 2021-09-30 | |
| 500,000 | 2022-11-03 | 10-Q | 2022 | Q3 | 2021-01-01 | 2021-09-30 | |
| 400,000 | 2021-11-03 | 10-Q | 2021 | Q3 | 2021-07-02 | 2021-09-30 | |
| 400,000 | 2022-11-03 | 10-Q | 2022 | Q3 | 2021-07-02 | 2021-09-30 | CY2021Q3 |
| 1,100,000 | 2022-05-04 | 10-Q | 2022 | Q1 | 2022-01-01 | 2022-03-31 | |
| 1,100,000 | 2023-05-03 | 10-Q | 2023 | Q1 | 2022-01-01 | 2022-03-31 | CY2022Q1 |
| 700,000 | 2022-08-03 | 10-Q | 2022 | Q2 | 2022-01-01 | 2022-06-30 | |
| 0.7 | 2023-08-02 | 10-Q | 2023 | Q2 | 2022-01-01 | 2022-06-30 | |
| 500,000 | 2022-08-03 | 10-Q | 2022 | Q2 | 2022-04-01 | 2022-06-30 | |
| 0.5 | 2023-08-02 | 10-Q | 2023 | Q2 | 2022-04-01 | 2022-06-30 | CY2022Q2 |
| 600,000 | 2022-11-03 | 10-Q | 2022 | Q3 | 2022-01-01 | 2022-09-29 | |
| 0.6 | 2023-11-01 | 10-Q | 2023 | Q3 | 2022-01-01 | 2022-09-29 | |
| 500,000 | 2022-11-03 | 10-Q | 2022 | Q3 | 2022-07-01 | 2022-09-29 | |
| 0.5 | 2023-11-01 | 10-Q | 2023 | Q3 | 2022-07-01 | 2022-09-29 | CY2022Q3 |
| 900,000 | 2023-05-03 | 10-Q | 2023 | Q1 | 2023-01-01 | 2023-03-30 | |
| 0.9 | 2024-05-07 | 10-Q | 2024 | Q1 | 2023-01-01 | 2023-03-30 | CY2023Q1 |
| 600,000 | 2023-08-02 | 10-Q | 2023 | Q2 | 2023-01-01 | 2023-06-29 | |
| 0.6 | 2024-08-05 | 10-Q | 2024 | Q2 | 2023-01-01 | 2023-06-29 | |
| 400,000 | 2023-08-02 | 10-Q | 2023 | Q2 | 2023-03-31 | 2023-06-29 | |
| 400,000 | 2024-08-05 | 10-Q | 2024 | Q2 | 2023-03-31 | 2023-06-29 | CY2023Q2 |
| 700,000 | 2023-11-01 | 10-Q | 2023 | Q3 | 2023-01-01 | 2023-09-28 | |
| 0.7 | 2024-11-05 | 10-Q | 2024 | Q3 | 2023-01-01 | 2023-09-28 | |
| 600,000 | 2023-11-01 | 10-Q | 2023 | Q3 | 2023-06-30 | 2023-09-28 | |
| 600,000 | 2024-11-05 | 10-Q | 2024 | Q3 | 2023-06-30 | 2023-09-28 | CY2023Q3 |
| 9,600,000 | 2024-05-07 | 10-Q | 2024 | Q1 | 2024-01-01 | 2024-03-28 | |
| 9.6 | 2025-05-01 | 10-Q | 2025 | Q1 | 2024-01-01 | 2024-03-28 | CY2024Q1 |
| 8,900,000 | 2024-08-05 | 10-Q | 2024 | Q2 | 2024-01-01 | 2024-06-27 | |
| 8,800,000 | 2024-08-05 | 10-Q | 2024 | Q2 | 2024-03-29 | 2024-06-27 | CY2024Q2 |
| 8,900,000 | 2024-11-05 | 10-Q | 2024 | Q3 | 2024-01-01 | 2024-09-26 | |
| 8,700,000 | 2024-11-05 | 10-Q | 2024 | Q3 | 2024-06-28 | 2024-09-26 | CY2024Q3 |
| 8,600,000 | 2025-05-01 | 10-Q | 2025 | Q1 | 2025-01-01 | 2025-04-03 | CY2025Q1 |
SEC Filings Explorer
Formalu provides easy access to SEC filings and reporting data
Most Recent Filings
2000 most recent SEC filings for the current official filing date
Aggregated Data
SEC filing data for all companies grouped by time and accounting terms
Formalu's Securities and Exchange Commission Page
SEC forms, contact information and locations